Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Exercise Tolerance | 23 | 2021 | 770 | 4.530 |
Why?
|
Exercise Test | 36 | 2024 | 2074 | 3.280 |
Why?
|
Hypertension, Pulmonary | 19 | 2021 | 1537 | 2.460 |
Why?
|
Fatigue Syndrome, Chronic | 4 | 2023 | 214 | 2.420 |
Why?
|
Exercise | 40 | 2023 | 5615 | 2.300 |
Why?
|
Vascular Resistance | 12 | 2021 | 936 | 1.520 |
Why?
|
Pulmonary Wedge Pressure | 8 | 2021 | 264 | 1.220 |
Why?
|
Anaerobic Threshold | 5 | 2019 | 52 | 1.190 |
Why?
|
Dyspnea | 9 | 2021 | 1303 | 1.140 |
Why?
|
Hemodynamics | 12 | 2021 | 4199 | 1.010 |
Why?
|
Cardiac Output | 9 | 2021 | 854 | 0.970 |
Why?
|
Oxygen Consumption | 17 | 2024 | 1869 | 0.940 |
Why?
|
Pulmonary Artery | 13 | 2021 | 1912 | 0.930 |
Why?
|
Postural Orthostatic Tachycardia Syndrome | 4 | 2024 | 54 | 0.810 |
Why?
|
Ventricular Dysfunction, Right | 4 | 2021 | 581 | 0.760 |
Why?
|
Pulmonary Ventilation | 9 | 2019 | 373 | 0.700 |
Why?
|
Ventricular Function | 2 | 2018 | 416 | 0.690 |
Why?
|
Pulmonary Gas Exchange | 12 | 2020 | 382 | 0.670 |
Why?
|
Connective Tissue Diseases | 1 | 2021 | 264 | 0.630 |
Why?
|
Atrial Function | 1 | 2018 | 107 | 0.630 |
Why?
|
Pulmonary Circulation | 8 | 2019 | 739 | 0.620 |
Why?
|
Stroke Volume | 16 | 2021 | 5007 | 0.620 |
Why?
|
Respiratory Mechanics | 9 | 2020 | 686 | 0.570 |
Why?
|
Microvessels | 1 | 2021 | 544 | 0.570 |
Why?
|
Lung Diseases, Obstructive | 5 | 1998 | 316 | 0.530 |
Why?
|
Muscle, Skeletal | 14 | 2013 | 4931 | 0.490 |
Why?
|
Lung Diseases | 4 | 2021 | 1886 | 0.490 |
Why?
|
Ventricular Function, Right | 5 | 2021 | 591 | 0.480 |
Why?
|
Ventricular Pressure | 4 | 2021 | 199 | 0.470 |
Why?
|
Physical Exertion | 5 | 2014 | 695 | 0.460 |
Why?
|
Respiration Disorders | 2 | 2014 | 371 | 0.460 |
Why?
|
Orthostatic Intolerance | 3 | 2022 | 20 | 0.460 |
Why?
|
Arteriovenous Fistula | 1 | 2016 | 315 | 0.440 |
Why?
|
Myocardial Contraction | 1 | 2018 | 1585 | 0.430 |
Why?
|
Alveolitis, Extrinsic Allergic | 2 | 2018 | 61 | 0.400 |
Why?
|
Lung Diseases, Interstitial | 1 | 2020 | 808 | 0.400 |
Why?
|
Heart Failure | 12 | 2024 | 10900 | 0.380 |
Why?
|
Chemoreceptor Cells | 4 | 2001 | 86 | 0.360 |
Why?
|
Catheterization, Peripheral | 1 | 2013 | 345 | 0.340 |
Why?
|
Phosphocreatine | 7 | 2011 | 269 | 0.340 |
Why?
|
Heart Rate | 8 | 2022 | 4091 | 0.330 |
Why?
|
Oxygen | 7 | 2022 | 4189 | 0.310 |
Why?
|
Lung | 7 | 2018 | 9856 | 0.290 |
Why?
|
Respiration | 6 | 2013 | 1653 | 0.280 |
Why?
|
Middle Aged | 49 | 2024 | 213383 | 0.270 |
Why?
|
Ultrasonography | 2 | 2018 | 5985 | 0.270 |
Why?
|
Heart Ventricles | 5 | 2021 | 3821 | 0.270 |
Why?
|
Hydrotherapy | 1 | 2005 | 6 | 0.270 |
Why?
|
Mycobacterium avium Complex | 1 | 2005 | 60 | 0.260 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 2005 | 76 | 0.250 |
Why?
|
Male | 66 | 2024 | 350118 | 0.250 |
Why?
|
Lung Transplantation | 6 | 2002 | 1153 | 0.240 |
Why?
|
Female | 66 | 2024 | 380194 | 0.240 |
Why?
|
Penicillanic Acid | 1 | 2024 | 45 | 0.240 |
Why?
|
Humans | 91 | 2024 | 744343 | 0.230 |
Why?
|
Ventriculography, First-Pass | 3 | 2008 | 20 | 0.230 |
Why?
|
Aged | 28 | 2021 | 163280 | 0.230 |
Why?
|
Lactates | 4 | 1998 | 432 | 0.230 |
Why?
|
Blood Pressure | 7 | 2022 | 8554 | 0.220 |
Why?
|
Lung Abscess | 2 | 2005 | 42 | 0.220 |
Why?
|
Carbon Dioxide | 5 | 2011 | 1150 | 0.220 |
Why?
|
Pyridostigmine Bromide | 1 | 2022 | 31 | 0.220 |
Why?
|
Mitochondria, Muscle | 5 | 2011 | 171 | 0.210 |
Why?
|
Perfusion Imaging | 2 | 2022 | 195 | 0.200 |
Why?
|
Posture | 2 | 2017 | 958 | 0.180 |
Why?
|
Sulfones | 4 | 2011 | 437 | 0.180 |
Why?
|
Fontan Procedure | 3 | 2014 | 778 | 0.180 |
Why?
|
Systole | 5 | 2021 | 958 | 0.170 |
Why?
|
Fatigue | 3 | 2023 | 1531 | 0.170 |
Why?
|
Respiratory System Agents | 1 | 1998 | 29 | 0.170 |
Why?
|
Elasticity | 1 | 2021 | 657 | 0.170 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2013 | 3047 | 0.170 |
Why?
|
Rest | 4 | 2016 | 901 | 0.160 |
Why?
|
Helium | 1 | 1998 | 123 | 0.160 |
Why?
|
Adult | 36 | 2024 | 214055 | 0.160 |
Why?
|
ROC Curve | 4 | 2018 | 3527 | 0.160 |
Why?
|
Intracellular Fluid | 1 | 1998 | 203 | 0.150 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2017 | 86 | 0.140 |
Why?
|
Echocardiography, Stress | 1 | 2017 | 131 | 0.140 |
Why?
|
Obesity | 2 | 2018 | 12745 | 0.140 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2017 | 314 | 0.140 |
Why?
|
Reflex | 1 | 1998 | 365 | 0.140 |
Why?
|
Extracellular Space | 1 | 1998 | 594 | 0.130 |
Why?
|
Oxygen Inhalation Therapy | 1 | 1998 | 367 | 0.130 |
Why?
|
Magnetic Resonance Spectroscopy | 10 | 2010 | 3760 | 0.130 |
Why?
|
Piperazines | 4 | 2011 | 2488 | 0.130 |
Why?
|
Iron-Sulfur Proteins | 1 | 2015 | 82 | 0.130 |
Why?
|
Cheyne-Stokes Respiration | 1 | 2014 | 38 | 0.130 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.130 |
Why?
|
Sulfur | 1 | 2015 | 166 | 0.120 |
Why?
|
Ventricular Outflow Obstruction | 1 | 2017 | 272 | 0.120 |
Why?
|
Bicycling | 1 | 2015 | 176 | 0.120 |
Why?
|
Forced Expiratory Volume | 3 | 2013 | 1743 | 0.120 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1738 | 0.120 |
Why?
|
Echocardiography | 5 | 2021 | 5102 | 0.120 |
Why?
|
Ventricular Function, Left | 2 | 2017 | 3670 | 0.120 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2011 | 2073 | 0.110 |
Why?
|
Echocardiography, Doppler | 1 | 2017 | 935 | 0.110 |
Why?
|
Inflammation Mediators | 1 | 2022 | 1889 | 0.110 |
Why?
|
Phenotype | 3 | 2021 | 16365 | 0.110 |
Why?
|
Feasibility Studies | 2 | 2021 | 5078 | 0.110 |
Why?
|
Physical Endurance | 2 | 2013 | 370 | 0.110 |
Why?
|
Heart | 2 | 2012 | 4467 | 0.110 |
Why?
|
Postpoliomyelitis Syndrome | 1 | 1992 | 11 | 0.100 |
Why?
|
Vasodilator Agents | 3 | 2020 | 977 | 0.100 |
Why?
|
Coronary Circulation | 1 | 2018 | 1572 | 0.100 |
Why?
|
Spirometry | 2 | 2014 | 864 | 0.100 |
Why?
|
Respiratory Function Tests | 4 | 2021 | 1616 | 0.100 |
Why?
|
Dextroamphetamine | 1 | 2012 | 129 | 0.100 |
Why?
|
Cerebrovascular Circulation | 1 | 2022 | 2731 | 0.100 |
Why?
|
Hydrogen-Ion Concentration | 4 | 1998 | 2557 | 0.100 |
Why?
|
Blood Gas Analysis | 3 | 2011 | 383 | 0.100 |
Why?
|
Patient Positioning | 3 | 2020 | 324 | 0.090 |
Why?
|
Tunica Media | 1 | 2010 | 113 | 0.090 |
Why?
|
Insulin Resistance | 4 | 2013 | 3864 | 0.090 |
Why?
|
Electrocardiography | 1 | 2024 | 6442 | 0.090 |
Why?
|
Ammonia | 1 | 1991 | 239 | 0.090 |
Why?
|
Pressure | 1 | 2013 | 1203 | 0.090 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1991 | 235 | 0.090 |
Why?
|
Heart Failure, Systolic | 1 | 2011 | 126 | 0.090 |
Why?
|
Veins | 1 | 2014 | 770 | 0.090 |
Why?
|
Mountaineering | 1 | 2010 | 45 | 0.090 |
Why?
|
Thoracotomy | 1 | 1991 | 363 | 0.090 |
Why?
|
Diet, Reducing | 1 | 2013 | 462 | 0.090 |
Why?
|
Growth | 1 | 2011 | 376 | 0.090 |
Why?
|
Gated Blood-Pool Imaging | 1 | 2008 | 44 | 0.080 |
Why?
|
Altitude Sickness | 1 | 2010 | 92 | 0.080 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2014 | 1240 | 0.080 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.080 |
Why?
|
Muscle Tonus | 1 | 2008 | 81 | 0.080 |
Why?
|
Physical Fitness | 1 | 2013 | 733 | 0.080 |
Why?
|
Tunica Intima | 1 | 2010 | 464 | 0.080 |
Why?
|
Heart Diseases | 2 | 1998 | 2788 | 0.080 |
Why?
|
Tracheostomy | 1 | 1992 | 401 | 0.080 |
Why?
|
Heart Defects, Congenital | 2 | 2014 | 4584 | 0.080 |
Why?
|
Prognosis | 5 | 2024 | 29063 | 0.080 |
Why?
|
Blood | 1 | 2010 | 598 | 0.080 |
Why?
|
National Institutes of Health (U.S.) | 2 | 2021 | 780 | 0.080 |
Why?
|
Lactic Acid | 4 | 2002 | 1133 | 0.080 |
Why?
|
Positive-Pressure Respiration | 1 | 1992 | 633 | 0.080 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 15076 | 0.070 |
Why?
|
Autoimmune Diseases | 1 | 2019 | 2133 | 0.070 |
Why?
|
Stavudine | 1 | 2007 | 85 | 0.070 |
Why?
|
MicroRNAs | 2 | 2015 | 3752 | 0.070 |
Why?
|
Autonomic Nervous System | 2 | 2022 | 671 | 0.070 |
Why?
|
Acidosis, Lactic | 2 | 1998 | 142 | 0.070 |
Why?
|
Phosphorus | 3 | 2007 | 338 | 0.070 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 215 | 0.070 |
Why?
|
Risk Reduction Behavior | 1 | 2013 | 1125 | 0.070 |
Why?
|
Area Under Curve | 3 | 2017 | 1654 | 0.070 |
Why?
|
Mitochondria | 2 | 2009 | 3520 | 0.070 |
Why?
|
Pilot Projects | 1 | 2018 | 8324 | 0.070 |
Why?
|
Human Growth Hormone | 1 | 2010 | 683 | 0.070 |
Why?
|
Energy Metabolism | 3 | 2010 | 2899 | 0.070 |
Why?
|
Purines | 4 | 2011 | 594 | 0.060 |
Why?
|
Muscles | 1 | 1990 | 1614 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2011 | 761 | 0.060 |
Why?
|
Reproducibility of Results | 4 | 2017 | 19905 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2013 | 1889 | 0.060 |
Why?
|
Remission, Spontaneous | 1 | 2005 | 382 | 0.060 |
Why?
|
Brain Abscess | 1 | 2005 | 118 | 0.060 |
Why?
|
Pneumonia, Aspiration | 1 | 2005 | 145 | 0.060 |
Why?
|
Vasoconstrictor Agents | 1 | 2008 | 642 | 0.060 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 882 | 0.060 |
Why?
|
Paresis | 1 | 2005 | 179 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2020 | 21746 | 0.060 |
Why?
|
Time Factors | 7 | 2017 | 40075 | 0.060 |
Why?
|
Athletes | 1 | 2011 | 1093 | 0.060 |
Why?
|
Sleep | 1 | 2019 | 4623 | 0.060 |
Why?
|
Central Nervous System Stimulants | 1 | 2012 | 1148 | 0.060 |
Why?
|
Reverse Transcriptase Inhibitors | 1 | 2007 | 615 | 0.060 |
Why?
|
Perfusion | 1 | 2008 | 1360 | 0.060 |
Why?
|
Positron-Emission Tomography | 1 | 2019 | 6234 | 0.060 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1312 | 0.060 |
Why?
|
Bronchoalveolar Lavage Fluid | 1 | 2005 | 768 | 0.050 |
Why?
|
Granuloma | 1 | 2005 | 319 | 0.050 |
Why?
|
Preoperative Care | 1 | 1991 | 2250 | 0.050 |
Why?
|
Prospective Studies | 4 | 2018 | 53288 | 0.050 |
Why?
|
Body Weight | 2 | 2010 | 4669 | 0.050 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2008 | 1504 | 0.050 |
Why?
|
Pulmonary Edema | 1 | 2005 | 414 | 0.050 |
Why?
|
Consensus | 2 | 2021 | 2959 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2024 | 77449 | 0.050 |
Why?
|
Cystic Fibrosis | 2 | 2002 | 1177 | 0.050 |
Why?
|
Connecticut | 1 | 2021 | 366 | 0.050 |
Why?
|
Oxidative Phosphorylation | 2 | 2013 | 481 | 0.040 |
Why?
|
Aged, 80 and over | 3 | 2019 | 57776 | 0.040 |
Why?
|
Disasters | 1 | 2005 | 511 | 0.040 |
Why?
|
Cytochrome b Group | 1 | 1998 | 60 | 0.040 |
Why?
|
Aerobiosis | 1 | 1998 | 106 | 0.040 |
Why?
|
Phosphodiesterase 5 Inhibitors | 2 | 2011 | 101 | 0.040 |
Why?
|
Mitochondrial Myopathies | 1 | 1998 | 47 | 0.040 |
Why?
|
DNA, Mitochondrial | 2 | 2007 | 817 | 0.040 |
Why?
|
United States | 7 | 2021 | 69872 | 0.040 |
Why?
|
Overweight | 1 | 2009 | 2371 | 0.040 |
Why?
|
Alkalosis | 1 | 1998 | 54 | 0.040 |
Why?
|
1-Naphthylamine | 1 | 1998 | 49 | 0.040 |
Why?
|
alpha 1-Antitrypsin Deficiency | 1 | 1998 | 107 | 0.040 |
Why?
|
Waiting Lists | 1 | 2002 | 692 | 0.040 |
Why?
|
Adolescent | 11 | 2021 | 85781 | 0.040 |
Why?
|
Nitrogen | 1 | 1998 | 344 | 0.040 |
Why?
|
Radiography | 1 | 2008 | 7023 | 0.040 |
Why?
|
Follow-Up Studies | 7 | 2021 | 39050 | 0.040 |
Why?
|
Puberty | 2 | 2011 | 490 | 0.040 |
Why?
|
Acid-Base Equilibrium | 1 | 1998 | 185 | 0.040 |
Why?
|
Vagus Nerve | 1 | 2019 | 438 | 0.040 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2012 | 3658 | 0.040 |
Why?
|
Diet | 1 | 1994 | 7939 | 0.030 |
Why?
|
Vital Capacity | 1 | 1998 | 925 | 0.030 |
Why?
|
Administration, Inhalation | 1 | 1998 | 1105 | 0.030 |
Why?
|
Sex Distribution | 1 | 2021 | 2297 | 0.030 |
Why?
|
Regression Analysis | 2 | 2010 | 6459 | 0.030 |
Why?
|
Phosphates | 2 | 1998 | 786 | 0.030 |
Why?
|
Supine Position | 1 | 2015 | 205 | 0.030 |
Why?
|
Glucose | 1 | 2007 | 4397 | 0.030 |
Why?
|
Diastole | 1 | 2016 | 791 | 0.030 |
Why?
|
Tricuspid Valve | 1 | 2017 | 403 | 0.030 |
Why?
|
Cardiovascular Diseases | 2 | 2018 | 15165 | 0.030 |
Why?
|
Brazil | 1 | 2018 | 1270 | 0.030 |
Why?
|
Risk Factors | 4 | 2016 | 72290 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2132 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 17446 | 0.030 |
Why?
|
Homeostasis | 2 | 2011 | 3340 | 0.030 |
Why?
|
Tricuspid Valve Insufficiency | 1 | 2017 | 349 | 0.030 |
Why?
|
Pneumonia | 1 | 2005 | 2133 | 0.030 |
Why?
|
Insulin-Like Growth Factor I | 2 | 2011 | 2015 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2005 | 12959 | 0.030 |
Why?
|
Young Adult | 6 | 2019 | 56430 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2024 | 25043 | 0.030 |
Why?
|
Hypertension | 1 | 2012 | 8480 | 0.030 |
Why?
|
Cohort Studies | 4 | 2022 | 40561 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2019 | 2077 | 0.030 |
Why?
|
Sodium Glutamate | 1 | 1991 | 27 | 0.030 |
Why?
|
Mood Disorders | 1 | 1998 | 1106 | 0.020 |
Why?
|
Nontherapeutic Human Experimentation | 1 | 2010 | 24 | 0.020 |
Why?
|
Sleep Apnea Syndromes | 1 | 1998 | 944 | 0.020 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2010 | 70 | 0.020 |
Why?
|
Environment, Controlled | 1 | 2010 | 46 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2013 | 555 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 1994 | 906 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 11725 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2009 | 183 | 0.020 |
Why?
|
Mutation, Missense | 1 | 1998 | 2564 | 0.020 |
Why?
|
Pulmonary Emphysema | 1 | 1994 | 672 | 0.020 |
Why?
|
Motor Activity | 2 | 2010 | 2714 | 0.020 |
Why?
|
Lipids | 2 | 2010 | 3305 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8663 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2618 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1150 | 0.020 |
Why?
|
Pain | 1 | 2023 | 4986 | 0.020 |
Why?
|
Whole-Body Irradiation | 1 | 1988 | 449 | 0.020 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2624 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.020 |
Why?
|
Gonadal Steroid Hormones | 1 | 2011 | 712 | 0.020 |
Why?
|
Glycemic Index | 1 | 2009 | 395 | 0.020 |
Why?
|
Child | 5 | 2014 | 77709 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 675 | 0.020 |
Why?
|
Sex Factors | 1 | 2021 | 10397 | 0.020 |
Why?
|
Survival Analysis | 2 | 2014 | 10252 | 0.020 |
Why?
|
Mitral Valve | 1 | 2015 | 1491 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 1998 | 8301 | 0.020 |
Why?
|
Glucose Clamp Technique | 1 | 2007 | 266 | 0.020 |
Why?
|
Tomography, X-Ray Computed | 3 | 2005 | 20129 | 0.020 |
Why?
|
Survival Rate | 2 | 2017 | 12788 | 0.020 |
Why?
|
Anxiety Disorders | 1 | 1998 | 2690 | 0.020 |
Why?
|
Dietary Fats | 1 | 1994 | 2017 | 0.020 |
Why?
|
Animals | 7 | 2015 | 168757 | 0.020 |
Why?
|
Carotid Arteries | 1 | 2010 | 952 | 0.020 |
Why?
|
Quality of Life | 1 | 2007 | 12804 | 0.020 |
Why?
|
Glycolysis | 1 | 1990 | 827 | 0.020 |
Why?
|
Cardiac Output, Low | 1 | 2006 | 195 | 0.020 |
Why?
|
Double-Blind Method | 2 | 2008 | 12026 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 1998 | 2838 | 0.020 |
Why?
|
Aphasia, Broca | 1 | 2005 | 50 | 0.020 |
Why?
|
Indonesia | 1 | 2005 | 119 | 0.020 |
Why?
|
Glutamine | 1 | 1988 | 578 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2011 | 13989 | 0.020 |
Why?
|
Empyema, Pleural | 1 | 2005 | 62 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2011 | 2025 | 0.020 |
Why?
|
Absorptiometry, Photon | 1 | 2010 | 1725 | 0.020 |
Why?
|
Cytokines | 1 | 2019 | 7322 | 0.020 |
Why?
|
Body Height | 1 | 2010 | 1577 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2019 | 4245 | 0.010 |
Why?
|
Energy Intake | 1 | 2011 | 2148 | 0.010 |
Why?
|
Algorithms | 1 | 2004 | 13881 | 0.010 |
Why?
|
Chronic Disease | 1 | 2018 | 9146 | 0.010 |
Why?
|
Patient Compliance | 1 | 2013 | 2684 | 0.010 |
Why?
|
Incidence | 1 | 2021 | 20947 | 0.010 |
Why?
|
Reference Values | 1 | 2010 | 4982 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2015 | 3479 | 0.010 |
Why?
|
Treatment Outcome | 4 | 2014 | 63114 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2009 | 849 | 0.010 |
Why?
|
Blood Transfusion | 1 | 1988 | 1301 | 0.010 |
Why?
|
Methotrexate | 1 | 1988 | 1727 | 0.010 |
Why?
|
Aging | 2 | 2011 | 8664 | 0.010 |
Why?
|
Psychomotor Performance | 1 | 2010 | 1901 | 0.010 |
Why?
|
Pneumothorax | 1 | 2005 | 379 | 0.010 |
Why?
|
Metabolomics | 1 | 2010 | 1484 | 0.010 |
Why?
|
Protons | 1 | 2007 | 1127 | 0.010 |
Why?
|
Heart Transplantation | 1 | 2014 | 3110 | 0.010 |
Why?
|
Rats | 1 | 1998 | 24260 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2011 | 2585 | 0.010 |
Why?
|
Recovery of Function | 1 | 2010 | 2925 | 0.010 |
Why?
|
Inflammation | 1 | 2019 | 10638 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 1998 | 7181 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19229 | 0.010 |
Why?
|
Radionuclide Ventriculography | 1 | 1998 | 41 | 0.010 |
Why?
|
Electron Transport Complex III | 1 | 1998 | 31 | 0.010 |
Why?
|
Coenzymes | 1 | 1998 | 91 | 0.010 |
Why?
|
Muscle Fatigue | 1 | 1998 | 83 | 0.010 |
Why?
|
Hospitalization | 1 | 2018 | 10262 | 0.010 |
Why?
|
Body Composition | 1 | 2007 | 2401 | 0.010 |
Why?
|
Ubiquinone | 1 | 1998 | 188 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.010 |
Why?
|
Feeding Behavior | 1 | 2009 | 3188 | 0.010 |
Why?
|
Blood Glucose | 1 | 2011 | 6256 | 0.010 |
Why?
|
Sertraline | 1 | 1998 | 206 | 0.010 |
Why?
|
Mice | 2 | 2015 | 81183 | 0.010 |
Why?
|
Cell Line | 1 | 2010 | 15997 | 0.010 |
Why?
|
Maximal Expiratory Flow-Volume Curves | 1 | 1994 | 25 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1998 | 1202 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6580 | 0.010 |
Why?
|
Postoperative Complications | 1 | 1997 | 15295 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1998 | 2839 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1998 | 2256 | 0.010 |
Why?
|
Body Mass Index | 1 | 2011 | 12720 | 0.010 |
Why?
|
Dogs | 2 | 1988 | 3912 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18370 | 0.010 |
Why?
|
Arousal | 1 | 1998 | 1165 | 0.010 |
Why?
|
Folic Acid | 1 | 1998 | 1300 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 1998 | 1940 | 0.010 |
Why?
|
Postoperative Period | 1 | 1994 | 1842 | 0.010 |
Why?
|
Boston | 1 | 2002 | 9313 | 0.010 |
Why?
|
Methionine Sulfoximine | 1 | 1988 | 12 | 0.010 |
Why?
|
Bronchoscopy | 1 | 1994 | 862 | 0.010 |
Why?
|
Glutamate-Ammonia Ligase | 1 | 1988 | 74 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2002 | 12245 | 0.010 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2005 | 4266 | 0.000 |
Why?
|
Proportional Hazards Models | 1 | 2002 | 12354 | 0.000 |
Why?
|
Base Sequence | 1 | 1998 | 12797 | 0.000 |
Why?
|
Glutamates | 1 | 1988 | 398 | 0.000 |
Why?
|
Histocompatibility Testing | 1 | 1988 | 741 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1998 | 13815 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1998 | 18111 | 0.000 |
Why?
|
Neurotransmitter Agents | 1 | 1988 | 647 | 0.000 |
Why?
|
Linear Models | 1 | 1994 | 5952 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2011 | 35421 | 0.000 |
Why?
|
Length of Stay | 1 | 1997 | 6309 | 0.000 |
Why?
|
Glutamic Acid | 1 | 1988 | 1169 | 0.000 |
Why?
|
gamma-Aminobutyric Acid | 1 | 1988 | 1121 | 0.000 |
Why?
|
Haplotypes | 1 | 1988 | 2779 | 0.000 |
Why?
|
Central Nervous System | 1 | 1988 | 1357 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1988 | 4776 | 0.000 |
Why?
|
Immune Tolerance | 1 | 1988 | 2258 | 0.000 |
Why?
|
Brain | 1 | 2005 | 26385 | 0.000 |
Why?
|
Models, Biological | 1 | 1988 | 9583 | 0.000 |
Why?
|